Austria Belgium Brazil Canada Denmark Finland France Germany Hungary Iceland Ireland Italy Luxembourg The Netherlands Norway Poland Spain Sweden Switzerland UK USA
Austria Belgium Brazil Canada Denmark Finland France Germany Hungary Iceland Ireland Italy Luxembourg The Netherlands Norway Poland Spain Sweden Switzerland UK USA
Austria Belgium Brazil Canada Denmark Finland France Germany Hungary Iceland Ireland Italy Luxembourg The Netherlands Norway Poland Spain Sweden Switzerland UK USA
Austria Belgium Brazil Canada Denmark Finland France Germany Hungary Iceland Ireland Italy Luxembourg The Netherlands Norway Poland Spain Sweden Switzerland UK USA
Austria Belgium Brazil Canada Denmark Finland France Germany Hungary Iceland Ireland Italy Luxembourg The Netherlands Norway Poland Spain Sweden Switzerland UK USA
Austria Belgium Brazil Canada Denmark Finland France Germany Hungary Iceland Ireland Italy Luxembourg The Netherlands Norway Poland Spain Sweden Switzerland UK USA
Austria Belgium Brazil Canada Denmark Finland France Germany Hungary Iceland Ireland Italy Luxembourg The Netherlands Norway Poland Spain Sweden Switzerland UK USA
The Danish pharmaceutical giant is experiencing unprecedented demand for its diabetes and weight-loss medications, a problem stemming from its own success.